Regulatory Roundup: Week of August 13: ISPE Issues Ozone Sanitization Guidance and EMA Amends Incident Management Plan

News
Article

Regulatory Roundup: ISPE issues ozone sanitization guidance and EMA amends incident management plan

ISPE has issued ISPE Good Practice Guide: Ozone Sanitization of Pharmaceutical Water Systems, a new guidance document on the design and use of ozone systems for pharmaceutical water sanitization. The guide offers insight on ozone sanitization systems, including regulatory considerations, system operation, and qualification of ozone systems, to allow pharmaceutical companies to better understand ozone systems.

The European Union Regulatory Network Incident Management Plan for Medicines for Human Use has been amended by EMA to reflect 2010 pharmacovigilance legislation. The plan, in operation since September 2009, explains how safety and other drug incidents are monitored and addressed by the EMA, the European Commission, and regulatory agencies across the EU.

Recent Videos
Roger Viney from ICE Pharma discusses the quality and compliance issues surrounding the use of animal-derived ingredients in the bio/pharma industry.
Tore Bergsteiner from MAIN5 discusses the most pertinent and impactful bio/pharma industry trends from 2024.
Simon Wright from Almac Pharma Services chats about shifting demand for commercial manufacturing services and how service providers are adapting to meet demand.
Ian Lafferty from Upperton discusses the trends and challenges facing sterile manufacturing and how partnering with CDMOs can help innovators progress to the market.
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.